Abstract
Neurally adjusted ventilatory assit (NAVA) is a new mode of mechanical ventilation that delivers ventilatory assist in proportion to neural effort. In contrast to all other modes of ventilation, which adopt conventional pneumatic signals (flow, volume, and airway pressure) to drive and control the ventilator operation, NAVA utilizes the electrical activity of the diaphragm. Ventilating neonatal and pediatric patients in this new mode appears to be safe and well tolerated with improved patient-ventilator synchrony and lower peak airway pressure when compared to pressure support ventilation. Concluding, NAVA improves monitoring of respiratory drive, and delivers synchronized assist in relation to patient effort, and the control of assist is not affected by leaks or auto-PEEP.
Keywords: NAVA, electrical activity of the diaphragm, pressure support ventilation, mechanical ventilation, partial ventilatory assist, pediatric, neonate, diaphragm, patient-ventilator interaction, asynchrony
Current Respiratory Medicine Reviews
Title: Neurally Adjusted Ventilatory Assist - NAVA
Volume: 8 Issue: 1
Author(s): Werther Brunow de Carvalho and Marcelo Cunio Machado Fonseca
Affiliation:
Keywords: NAVA, electrical activity of the diaphragm, pressure support ventilation, mechanical ventilation, partial ventilatory assist, pediatric, neonate, diaphragm, patient-ventilator interaction, asynchrony
Abstract: Neurally adjusted ventilatory assit (NAVA) is a new mode of mechanical ventilation that delivers ventilatory assist in proportion to neural effort. In contrast to all other modes of ventilation, which adopt conventional pneumatic signals (flow, volume, and airway pressure) to drive and control the ventilator operation, NAVA utilizes the electrical activity of the diaphragm. Ventilating neonatal and pediatric patients in this new mode appears to be safe and well tolerated with improved patient-ventilator synchrony and lower peak airway pressure when compared to pressure support ventilation. Concluding, NAVA improves monitoring of respiratory drive, and delivers synchronized assist in relation to patient effort, and the control of assist is not affected by leaks or auto-PEEP.
Export Options
About this article
Cite this article as:
Brunow de Carvalho Werther and Cunio Machado Fonseca Marcelo, Neurally Adjusted Ventilatory Assist - NAVA, Current Respiratory Medicine Reviews 2012; 8 (1) . https://dx.doi.org/10.2174/157339812798868825
DOI https://dx.doi.org/10.2174/157339812798868825 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Use of Clinically Available PPAR Agonists for Heart Failure; Do the Risks Outweigh the Potential Benefits?
Current Molecular Pharmacology Advancement in Microsponge Drug Delivery System: Preparation Methods, Patents and Commercial Utility
Recent Patents on Drug Delivery & Formulation Visfatin/PBEF and Atherosclerosis-Related Diseases
Current Vascular Pharmacology Alternative Therapies for Diabetes: A Comparison of Western and Traditional Chinese Medicine (TCM) Approaches
Current Diabetes Reviews High-Density Lipoprotein-Mediated Anti-Atherosclerotic and Endothelial-Protective Effects: A Potential Novel Therapeutic Target in Cardiovascular Disease
Current Pharmaceutical Design Curative Effects of <i>Dhatryadi ghrita</i> Bioactive Extracts on Ethanol Withdrawal Syndrome in Wistar Rats
Current Bioactive Compounds Goal Directed Fluid Therapy
Current Pharmaceutical Design Editorial
Recent Patents on Food, Nutrition & Agriculture Single Photon Emission Tomography in the Diagnostic Assessment of Cardiac and Vascular Infectious Diseases
Current Radiopharmaceuticals Emerging Risk Factors for Dementia: The Role of Blood Pressure Variability
CNS & Neurological Disorders - Drug Targets Management of Obesity in Patients with Type 2 Diabetes Mellitus
Current Diabetes Reviews Atherosclerotic Coronary Heart Disease Epidemiology, Classification and Management
Cardiovascular & Hematological Disorders-Drug Targets Editorial: (Thematic Issue: Plant Polyphenols and Health Benefits)
Current Pharmaceutical Design Immune-Neuroendocrine Interactions Involving Thymus and Pineal Gland in Stem Cell Therapy of Age-Related Diseases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Imaging Techniques as an Aid in the Early Detection of Cardiac Amyloidosis
Current Pharmaceutical Design Milestones in Antihypertensive Drug Treatment
Current Pharmaceutical Design Metabolic Syndrome, Mild Cognitive Impairment and Dementia
Current Alzheimer Research Antithrombotic Treatment in Diabetes Mellitus: A Review of the Literature about Antiplatelet and Anticoagulation Strategies Used for Diabetic Patients in Primary and Secondary Prevention
Current Pharmaceutical Design Can the Electrophysiological Action of Rosiglitazone Explain its Cardiac Side Effects?
Current Medicinal Chemistry Sleep Duration as a Risk Factor for Cardiovascular Disease- a Review of the Recent Literature
Current Cardiology Reviews